TITLE

Early intervention in schizophrenia: three frameworks for guiding ethical inquiry Ethics in early intervention

AUTHOR(S)
Candilis, Philip J.
PUB. DATE
December 2003
SOURCE
Psychopharmacology;2003, Vol. 171 Issue 1, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Psychiatric research is making important strides toward early detection and treatment of schizophrenia. Discovery of genetic markers, identifiable prodromes, and low-risk interventions fuel this vital scientific movement. At the same time, investigators and clinicians are studying the ethical questions that arise whenever the bounds of diagnosis and treatment are evolving rapidly. This ethical analysis generally falls within three dominant frameworks of bioethics: the conceptualization of disease, scientific uncertainty, and risk-factor ethics. These frameworks are explored as potential guides for directing ethical inquiry in early intervention.
ACCESSION #
11581790

 

Related Articles

  • Number of STR Repeats as a Potential New Quantitative Genetic Marker for Complex Diseases, Illustrated by Schizophrenia. Hui Liu; Weijian Yu; Xuebin Wang; Fang Fang; Guang Yang; Jie Zhou; Xiaohua Liang; Wanxin An // Biochemical Genetics;Oct2007, Vol. 45 Issue 9/10, p683 

    Abstract  It has proved difficult to find strong and replicable genetic linkages for complex diseases, since each susceptibility gene makes only a modest contribution to onset. This is partly because high-efficacy genetic markers are not usually available. The aim of this article is to...

  • microRNAs as novel biomarkers of schizophrenia (Review). JIE WANG; YUHAN WANG; JIANBO YANG; YUANSHUAI HUANG // Experimental & Therapeutic Medicine;2014, Vol. 8 Issue 6, p1671 

    Schizophrenia is a severe mental illness and the most common complex neuropsychiatric disorder. To date, the etiology of schizophrenia is unclear; consequently, the diagnosis of schizophrenia is controversial. Biomarkers that reflect the dysregulations observed in schizophrenia may potentially...

  • Glycine Reuptake Inhibitors in the Treatment of Negative Symptoms of Schizophrenia. Thomas, Reji; Baker, Glen; Dursun, Serdar; Todd, Kathryn; Dhami, Kamaldeep; Chue, James; Chue, Pierre // Klinik Psikofarmakoloji Bulteni;2014, Vol. 24 Issue 3, p195 

    Negative symptoms are present in over one quarter of patients with schizophrenia and are detrimental to prognosis, functionality and quality of life. Currently, the treatments for primary negative symptoms are inadequate. However, enhancing N-methyl-D-aspartate receptor hypofunctioning with...

  • Test of Xq26.3-28 linkage in bipolar and unipolar affective disorder in families selected for absence of male to male transmission. Smyth, C.; Kalsi, G.; Brynjolfsson, J.; O'Neill, J.; Curtis, D.; Rifkin, L.; Moloney, E.; Murphy, P.; Petursson, H.; Gurling, H. // British Journal of Psychiatry;Dec97, Vol. 171, p578 

    Background: There have been several reports of linkage between genetic markers on the X chromosome at Xq26.3-28 and bipolar affective disorder in family samples obtained from distinct ethnic and geographical origins. As part of a genome search in a series of 23 UK and Icelandic...

  • Optimal Positioning of Markers to Control Genetic Background in Marker-Assisted Backcrossing. Servin, B.; Hospital, F. // Journal of Heredity;May/Jun2002, Vol. 93 Issue 3, p214 

    Presents information on a study which computed an optimal positioning of markers to control genetic background in marker-assisted backcrossing. Aim of a backcross selection program; Methodology; Results and discussion.

  • The Diagnostic Specificity of Negative Symptoms and their Psychopathological Context. Mundt, Ch.; Kasper, S.; Huerkamp, M. // British Journal of Psychiatry;Nov89 Supplement, Vol. 155, p32 

    The article reports on the diagnostic specificity of negative symptoms and their psychopathological context. Basic symptoms, rating scales for negative symptoms, and other comparable psychopathological syndromes were not constructed in order to make psychiatric diagnoses nor it is intended to be...

  • Association of the hSERT and SLC6A4 Polymorphic Markers of the Serotonin Transporter Gene with Schizophrenia in Two Ethnic Groups. Zainullina, A. G.; Juriev, E. B.; Bikbulatova, S. R.; Khusnutdinova, E. K. // Molecular Biology;Jul/Aug2003, Vol. 37 Issue 4, p508 

    Insertion/deletion and VNTR polymorphisms of the serotonin transporter gene were tested for association with schizophrenia in patients of different ethnicity. A difference in genetic predisposition was observed for continuous and shift-like schizophrenia forms, the former tending to be...

  • Characterization of Admixture in an Urban Sample from Buenos Aires, Argentina, Using Uniparentally and Biparentally Inherited Genetic Markers. Martínez Marignac, Verónica L.; Bertoni, Bernardo; Parra, Esteban J.; Blanchi, Nestor O. // Human Biology;Aug2004, Vol. 76 Issue 4, p543 

    In this study we analyzed a sample of the urban population of La Plata, Argentina, using 17 mtDNA haplogroups, the DYS199 Y-chromosome polymorphism, and 5 autosomal population-associated alleles (PAAs). The contribution of native American maternal lineages to the population of La Plata was...

  • Doxiciclina em pacientes com linfangioleiomiomatose: biomarcadores e resposta funcional pulmonar. Pimenta, Suzana Pinheiro; Baldi, Bruno Guedes; Kairalla, Ronaldo Adib; Carvalho, Carlos Roberto Ribeiro // Jornal Brasileiro de Pneumologia;ene/feb2013, Vol. 39 Issue 1, p5 

    Objective: To assess blockade of matrix metalloproteinase (MMP)-2 and MMP-9, as well as the variation in FEV1, in patients with lymphangioleiomyomatosis (LAM) treated with doxycycline (a known MMP inhibitor) for 12 months. Methods: An open-label, single-arm, interventional clinical trial in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics